| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2005PNAS..102..267S |
| P356 | DOI | 10.1073/PNAS.0406835101 |
| P8608 | Fatcat ID | release_lnhhfxo4abbqbbxlga3vo4xsb4 |
| P932 | PMC publication ID | 544292 |
| P698 | PubMed publication ID | 15625112 |
| P5875 | ResearchGate publication ID | 8106076 |
| P2093 | author name string | Michael D Ward | |
| Jeffrey A Wesson | |||
| Taesung Jung | |||
| Xiaoxia Sheng | |||
| P2860 | cites work | Chemical and biochemical analysis using scanning force microscopy | Q77367225 |
| Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins | Q93533841 | ||
| The cDNA and derived amino acid sequence for human osteopontin | Q24635888 | ||
| Inhibition of calcium oxalate crystal growth and aggregation by prothrombin and its fragments in vitro: relationship between protein structure and inhibitory activity. | Q30322820 | ||
| Atomic force microscopy of the electrochemical nucleation and growth of molecular crystals | Q33297699 | ||
| Atomic force microscopy of crystalline insulins: the influence of sequence variation on crystallization and interfacial structure | Q34167730 | ||
| Bulk crystals to surfaces: combining X-ray diffraction and atomic force microscopy to probe the structure and formation of crystal interfaces | Q34440485 | ||
| Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle | Q34834615 | ||
| Molecular modulation of calcium oxalate crystallization by osteopontin and citrate | Q36603473 | ||
| Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily | Q36778774 | ||
| Glycosaminoglycans as inhibitors of calcium oxalate crystal growth and aggregation | Q39286733 | ||
| Regulation of renal epithelial cell affinity for calcium oxalate monohydrate crystals | Q40902061 | ||
| Surface exposure of phosphatidylserine increases calcium oxalate crystal attachment to IMCD cells | Q41141403 | ||
| Increased calcium oxalate crystal nucleation and aggregation by peroxidized protein of human kidney stone matrix and renal cells | Q43693581 | ||
| Aggregation and dispersion characteristics of calcium oxalate monohydrate: effect of urinary species | Q44264965 | ||
| Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules | Q44265632 | ||
| Adhesion between molecules and calcium oxalate crystals: critical interactions in kidney stone formation | Q44344821 | ||
| Whole urinary proteins coat calcium oxalate monohydrate crystals to greatly decrease their adhesion to renal cells | Q44471702 | ||
| Probing crystallization of calcium oxalate monohydrate and the role of macromolecule additives with in situ atomic force microscopy | Q45067118 | ||
| Thermodynamics of calcite growth: baseline for understanding biomineral formation | Q46291491 | ||
| Scanning electron microscopy and molecular modeling of inhibition of calcium oxalate monohydrate crystal growth by citrate and phosphocitrate | Q61773835 | ||
| The expectation of free and fixed particles in urinary stone disease | Q67327470 | ||
| Effects of human urine on aggregation of calcium oxalate crystals | Q69991109 | ||
| Morphological effects of glycosaminoglycans on calcium oxalate monohydrate crystals | Q71564573 | ||
| Evidence for aggregation in oxalate stone formation: atomic force and low voltage scanning electron microscopy | Q71667966 | ||
| The effect of urine, pyrophosphate, citrate, magnesium and glycosaminoglycans on the growth and aggregation of calcium oxalate crystals in vitro | Q72894084 | ||
| Calcium oxalate nephrolithiasis, a free or fixed particle disease | Q72898118 | ||
| Surface characterization of aspirin crystal planes by dynamic chemical force microscopy | Q74204569 | ||
| Contact mechanics modeling of pull-off measurements: effect of solvent, probe radius, and chemical binding probability on the detection of single-bond rupture forces by atomic force microscopy | Q74522240 | ||
| Osteopontin antisense oligonucleotide inhibits adhesion of calcium oxalate crystals in Madin-Darby canine kidney cell | Q77342542 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | calcium oxalate | Q412399 |
| P304 | page(s) | 267-272 | |
| P577 | publication date | 2004-12-29 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Adhesion at calcium oxalate crystal surfaces and the effect of urinary constituents | |
| P478 | volume | 102 |
| Q34478518 | A fast response mechanism for insulin storage in crystals may involve kink generation by association of 2D clusters |
| Q37379491 | Alpha-enolase on apical surface of renal tubular epithelial cells serves as a calcium oxalate crystal receptor |
| Q42919584 | Attachment of Calcium Oxalate Monohydrate Crystals on Patterned Surfaces of Proteins and Lipid Bilayers |
| Q50496581 | Bacteria can promote calcium oxalate crystal growth and aggregation. |
| Q35050995 | Calcium oxalate monohydrate aggregation induced by aggregation of desialylated Tamm-Horsfall protein |
| Q58465160 | Chemistry-Specific Interfacial Forces Between Barnacle (Semibalanus Balanoides) Cyprid Footprint Proteins and Chemically Functionalised AFM Tips |
| Q58454458 | Citrate Modulates Calcium Oxalate Crystal Growth by Face-Specific Interactions |
| Q33568547 | Composition and morphology of nanocrystals in urines of lithogenic patients and healthy persons |
| Q34624373 | Crystal growth inhibitors for the prevention of L-cystine kidney stones through molecular design |
| Q35899117 | Cystine growth inhibition through molecular mimicry: a new paradigm for the prevention of crystal diseases |
| Q41564960 | Developing a molecular picture of soil organic matter-mineral interactions by quantifying organo-mineral binding. |
| Q88733076 | Development of a two-stage in vitro model system to investigate the mineralization mechanisms involved in idiopathic stone formation: stage 1-biomimetic Randall's plaque using decellularized porcine kidneys |
| Q55686457 | Effect of Crystal Shape and Aggregation of Calcium Oxalate Monohydrate on Cellular Toxicity in Renal Epithelial Cells. |
| Q36070242 | Exploring calcium oxalate crystallization: a constant composition approach |
| Q37408555 | Face-specific binding of prothrombin fragment 1 and human serum albumin to inorganic and urinary calcium oxalate monohydrate crystals |
| Q51177779 | Gender-related effects on urine L-cystine metastability. |
| Q39405553 | Hyperoxaluria Requires TNF Receptors to Initiate Crystal Adhesion and Kidney Stone Disease. |
| Q37633953 | Hypocitraturia: pathophysiology and medical management. |
| Q92494538 | In Vitro Studies Reveal Antiurolithic Effect of Antioxidant Sulfated Polysaccharides from the Green Seaweed Caulerpa cupressoides var flabellata |
| Q46893722 | In situ imaging of silicalite-1 surface growth reveals the mechanism of crystallization |
| Q90654717 | Incorporation of osteopontin peptide into kidney stone-related calcium oxalate monohydrate crystals: a quantitative study |
| Q24536113 | Kidney stone disease |
| Q84320563 | Lithogenic activity and clinical relevance of lipids extracted from urines and stones of nephrolithiasis patients |
| Q42972093 | Mineralogical signatures of stone formation mechanisms |
| Q79988047 | Models for protein binding to calcium oxalate surfaces |
| Q24649072 | Modulation of calcium oxalate dihydrate growth by selective crystal-face binding of phosphorylated osteopontin and polyaspartate peptide showing occlusion by sectoral (compositional) zoning |
| Q46979143 | Morphology of crystals in calcium oxalate monohydrate kidney stones |
| Q39948151 | NF-kappaB activation in renal tubular epithelial cells by oxalate stimulation. |
| Q26865804 | Nephropathy in dietary hyperoxaluria: A potentially preventable acute or chronic kidney disease |
| Q38028473 | New opportunities in crystal engineering--the role of atomic force microscopy in studies of molecular crystals |
| Q37345818 | Phosphorylation of osteopontin is required for inhibition of calcium oxalate crystallization |
| Q24656138 | Quantitative assessment of citric acid in lemon juice, lime juice, and commercially-available fruit juice products |
| Q38719523 | Response of renal tubular cells to differential types and doses of calcium oxalate crystals: Integrative proteome network analysis and functional investigations |
| Q37202772 | SLC26A6 and NaDC-1 transporters interact to regulate oxalate and citrate homeostasis |
| Q35940200 | Specific adsorption of osteopontin and synthetic polypeptides to calcium oxalate monohydrate crystals |
| Q37475365 | Subnanometer atomic force microscopy of peptide-mineral interactions links clustering and competition to acceleration and catastrophe |
| Q37206519 | Surface aggregation of urinary proteins and aspartic Acid-rich peptides on the faces of calcium oxalate monohydrate investigated by in situ force microscopy |
| Q57492018 | The Long Pentraxin PTX3 Is an Endogenous Inhibitor of Hyperoxaluria-Related Nephrocalcinosis and Chronic Kidney Disease |
| Q39028115 | The role of macromolecules in the formation of kidney stones |
| Q34100411 | Urinary citrate excretion in healthy children depends on age and gender. |
| Q58107873 | Vision for the future on urolithiasis: research, management, education and training-some personal views |
| Q39024105 | What does the crystallography of stones tell us about their formation? |
Search more.